Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways.

MLA

Wallerand, Hervé, et al. “Targeted Therapies in Non-Muscle-Invasive Bladder Cancer According to the Signaling Pathways.” Urologic Oncology, vol. 29, no. 1, Jan. 2011, pp. 4–11. EBSCOhost, https://doi.org/10.1016/j.urolonc.2009.07.025.

APA

Wallerand, H., Bernhard, J.-C., Culine, S., Ballanger, P., Robert, G., Reiter, R. E., Ferrière, J.-M., & Ravaud, A. (2011). Targeted therapies in non-muscle-invasive bladder cancer according to the signaling pathways. Urologic Oncology, 29(1), 4–11. https://doi.org/10.1016/j.urolonc.2009.07.025

Chicago

Wallerand, Hervé, Jean-Christophe Bernhard, Stéphane Culine, Philippe Ballanger, Grégoire Robert, Robert E Reiter, Jean-Marie Ferrière, and Alain Ravaud. 2011. “Targeted Therapies in Non-Muscle-Invasive Bladder Cancer According to the Signaling Pathways.” Urologic Oncology 29 (1): 4–11. doi:10.1016/j.urolonc.2009.07.025.